MCDB 131 was developed by Knedler and Ham as a reduced serum-supplemented medium for the culture of human microvascular endothelial cells. This formulation has been reported to support clonal growth of human omental microvascular cells when supplemented with 0.7% dialyzed FBS, 10ng/mL EGF, and 1ug/mL hydrocortisone.||Appearance: |Pale orange to orange, homogeneous, free-flowing powder ||Solubility: |Pink to red or orange, clear, complete||pH: |As Reported||Endotoxin: |≤1EU/ml